antibody Lab Reagents for Research





Promoted Lab recombinants

ASAP1 antibody Antibody

DF8746 Affbiotech 200ul 420 EUR

CD11b Antibody Antibody

ABD2911 Lifescience Market 100 ug 525.6 EUR

anti- Antibody^Polyclonal antibody control antibody

LSMab09882 Lifescience Market 100 ug 525.6 EUR

ARHGDIA Antibody / RHOGDI Antibody

F54788-0.08ML NSJ Bioreagents 0.08 ml 165 EUR

ARHGDIA Antibody / RHOGDI Antibody

F54788-0.4ML NSJ Bioreagents 0.4 ml 379 EUR

Antibody

A1360-500 Biovision each Ask for price

ASAP1 antibody Antibody

DF8746 Affbiotech 200ul 420 EUR

CD11b Antibody Antibody

ABD2911 Lifescience Market 100 ug 525.6 EUR

anti- Antibody^Polyclonal antibody control antibody

LSMab09882 Lifescience Market 100 ug 525.6 EUR

ARHGDIA Antibody / RHOGDI Antibody

F54788-0.08ML NSJ Bioreagents 0.08 ml 165 EUR

ARHGDIA Antibody / RHOGDI Antibody

F54788-0.4ML NSJ Bioreagents 0.4 ml 379 EUR

Antibody

A1360-500 Biovision each Ask for price

Ly1 Antibody Reactive (LYAR) Antibody

20-abx123734 Abbexa
  • 493.20 EUR
  • 710.40 EUR
  • 100 ul
  • 200 ul

Our used rec. in Pubmed.

MOTILITY TEST MEDIUM

M13-121-10kg Alphabiosciences 10 kg 1833.6 EUR

MOTILITY TEST MEDIUM

M13-121-2Kg Alphabiosciences 2 Kg 445.2 EUR

MOTILITY TEST MEDIUM

M13-121-500g Alphabiosciences 500 g 164.4 EUR

SNYDER TEST AGAR

S19-119-10kg Alphabiosciences 10 kg 1258.8 EUR

SNYDER TEST AGAR

S19-119-2Kg Alphabiosciences 2 Kg 320.4 EUR

SNYDER TEST AGAR

S19-119-500g Alphabiosciences 500 g 130.8 EUR

SAM Test Strip

TS00201s-30 Arthus 30 tests 499.2 EUR

SAH Test Strip

TS00301s-30 Arthus 30 tests 604.8 EUR

HCY Test Strip

TS00401s-30 Arthus 30 tests 663.6 EUR

Test Tube 16x100mm

3840/16X100 Scientific Laboratory Supplies PK100 57.11 EUR

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Post

Targeting CD99 compromises the oncogenic effects of the chimera EWS-FLI1 by inducing re-expression of zyxin and inhibition of Gli1 activity

Targeting CD99 compromises the oncogenic effects of the chimera EWS-FLI1 by inducing re-expression of zyxin and inhibition of Gli1 activityTargeting CD99 compromises the oncogenic effects of the chimera EWS-FLI1 by inducing re-expression of zyxin and inhibition of Gli1 activity

Ewing sarcoma (EWS), a extremely aggressive pediatric tumor, is pushed by EWS-FLI1, an oncogenic transcription issue that remodels the tumor genetic panorama. Epigenetic mechanisms play a pivotal function in EWS